Ciliary Body Procedures in Glaucoma: A Narrative Review from the Past to the Future
DOI:
https://doi.org/10.48560/rspo.32010Keywords:
Ciliary Body, Glaucoma, High-Intensity Focused Ultrasound Ablation, Laser CoagulationAbstract
Ciliary body treatments have been used in glaucoma for many decades. They reduce the intraocular pressure by decreasing the aqueous humour production. Initially, the developed techniques, like cyclocryotherapy, had high rates of complications and were reserved only for advanced and refractory glaucoma. In recent years, other procedures such as laser cyclophoto-coagulation (endoscopic and transscleral) or ultrasound cycloprocedures have replaced the older techniques due to their safer characteristics. We recognize that there has been a great evolution throughout the years, moving from more aggressive techniques with serious postoperative complications to procedures with an excellent safety profile and effectiveness. Their indications are still evolving, and further studies are needed to elucidate the ideal timing of treatment and the best parameters. This review aims to understand the current role of cycloprocedures in glaucoma, describe the available modalities and compare the most used techniques.Downloads
References
Quigley HA. Glaucoma. Lancet. 2011;377:1367-77. doi:10.1016/S0140-6736(10)61423-7
Anand N, Klug E, Nirappel A, Solá-Del Valle D. A review of cyclodestructive procedures for the treatment of glaucoma. Semin Ophthalmol. 2020;35:261-75. doi:10.1080/08820538.2020.1810711
Michelessi M, Bicket AK, Lindsley K. Cyclodestructive procedures for non‐refractory glaucoma. Cochrane Database Syst Rev. 2018;2018. doi:10.1002/14651858.CD009313.
Dastiridou AI, Katsanos A, Denis P, Francis BA, Mikropoulos DG, Teus MA, et al. Cyclodestructive procedures in glaucoma: a review of current and emerging Options. Adv Ther. 2018;35:2103-27. doi:10.1007/S12325-018-0837-3
Lee DA, Higginbotham EJ. Glaucoma and its treatment: a review. Am J Health Syst Pharm. 2005;62:691-9. doi:10.1093/AJHP/62.7.691
Verhoeff FH. Cyclectomy: a new operation for glaucoma. Arch Ophthalmol. 1924;53:228-9.
Mastrobattista JM, Luntz M. Ciliary body ablation: where are we and how did we get here? Surv Ophthalmol. 1996;41:193-213. doi:10.1016/S0039-6257(96)80023-3
Prost M. Cyclocryotherapy for glaucoma. Evaluation of techniques. Surv Ophthalmol. 1983;28:93-100. doi:10.1016/00396257(83)90077-2
Ndulue JK, Rahmatnejad K, Sanvicente C, Wizov SS, Moster MR. Evolution of Cyclophotocoagulation. J Ophthalmic Vis Res. 2018;13:55. doi:10.4103/JOVR.JOVR_190_17
Lai J, Choy BN, Shum JW. Management of Primary Angle-Closure Glaucoma. Asia Pac J Ophthalmol. 2016;5:59-62. doi:10.1097/APO.0000000000000180
Beckman H, Kinoshita A, Rosa A, Sugar H. Transscleral ruby laser irradiation of the ciliary body in the treatment of intractable glaucoma. Trans Am Acad Ophthalmol Otolaryngol. 1972;72:423-36.
Mastropasqua R, Fasanella V, Mastropasqua A, Ciancaglini M, Agnifili L. High-Intensity Focused Ultrasound Circular Cyclocoagulation in Glaucoma: A Step Forward for Cyclodestruction? J Ophthalmol. 2017;2017:7136275. doi:10.1155/2017/7136275
Bloom P, Negi A, Kersey T, Crawley L. Cyclodestructive techniques. In: Shaarawy T, Sherwood M, Hitchings R, Crowston J, editors. Glaucoma. 2nd ed. Amsterdam: Elsevier; 2015. p.1150-9.
Tóth M, Shah A, Hu K, Bunce C, Gazzard G. Endoscopic cyclophotocoagulation (ECP) for open angle glaucoma and primary angle closure. Cochrane Database Syst Rev. 2019;2019. doi:10.1002/14651858.CD012741.pub2
Roberto GC. Cyclophotocoagulation. In: Spaeth GL, Danesh-Meyer H, Goldberg I, Kampik A, editors. Ophthalmic Surgery: Principles and Practice. Amsterdam: Elsevier Health Sciences; 2011.
Souissi S, Le Mer Y, Metge F, Portmann A, Baudouin C, Labbé A, et al. An update on continuous-wave cyclophotocoagulation (CW-CPC) and micropulse transscleral laser treatment (MP-TLT) for adult and paediatric refractory glaucoma. Acta Ophthalmol. 2021;99:e621-53. doi:10.1111/AOS.14661
Khodeiry MM, Liu X, Sheheitli H, Sayed MS, Lee RK. Slow Coagulation Transscleral Cyclophotocoagulation for Postvitrectomy Patients With Silicone Oil-induced Glaucoma. J Glaucoma. 2021;30:789-94. doi:10.1097/IJG.0000000000001893
Duerr ERH, Sayed MS, Moster SJ, Holley T, Peiyao J, Vanner EA, et al. Transscleral diode laser cyclophotocoagulation: a comparison of slow coagulation and standard coagulation techniques. Ophthalmol Glaucoma. 2018;1:115-22. doi:10.1016/J.OGLA.2018.08.007
Murphy CC, Burnett CA, Spry PG, Broadway DC, Diamond JP. A two centre study of the dose-response relation for transscleral diode laser cyclophotocoagulation in refractory glaucoma. Br J Ophthalmol. 2003;87:1252-7. doi:10.1136/BJO.87.10.1252
Frezzotti P, Mittica V, Martone G, Motolese I, Lomurno L, Peruzzi S, et al. Longterm follow-up of diode laser transscleral cyclophotocoagulation in the treatment of refractory glaucoma. Acta Ophthalmol. 2010;88(1):150-155. doi:10.1111/J.1755-3768.2008.01354.X
Yildirim N, Yalvac IS, Sahin A, Ozer A, Bozca T. A comparative study between diode laser cyclophotocoagulation and the Ahmed glaucoma valve implant in neovascular glaucoma: a long-term follow-up. J Glaucoma. 2009;18:192-6. doi:10.1097/IJG.0B013E31817D235C
Kirwan JF, Shah P, Khaw PT. Diode laser cyclophotocoagulation: role in the management of refractory pediatric glaucomas. Ophthalmology. 2002;109:316-23. doi:10.1016/S01616420(01)00898-3
Ma A, Yu SWY, Wong JK. Micropulse laser for the treatment of glaucoma: A literature review. Surv Ophthalmol. 2019;64:48697. doi:10.1016/J.SURVOPHTHAL.2019.01.001
Sanchez FG, Peirano-Bonomi JC, Brossard Barbosa N, Khoueir Z, Grippo TM. Update on Micropulse Transscleral Cyclophotocoagulation. J Glaucoma. 2020;29:598-603. doi:10.1097/IJG.0000000000001539
Basto RC, Almeida J, Roque JN, et al. Clinical Outcomes of Micropulse Transscleral Cyclophotocoagulation: 2 Years of Experience in Portuguese Eyes. J Curr Glaucoma Pract. 2023;17:30. doi:10.5005/JP-JOURNALS-10078-1395
Shaarawy TM, Sherwood MB, Grehn F, editors. Guidelines on Design and Reporting of Glaucoma Surgical Trials Editors. Amsterdam: Kluger Publications; 2009.
Varikuti VNV, Shah P, Rai O, Chaves AC, Miranda A, Lim BA, et al. Outcomes of micropulse transscleral cyclophotocoagulation in eyes with good central vision. J Glaucoma. 2019;28:901-5. doi:10.1097/IJG.0000000000001339
Aquino MC, Barton K, Tan AM, Sng C, Li X, Loon SC, et al. Micropulse versus continuous wave transscleral diode cyclophotocoagulation in refractory glaucoma: a randomized exploratory study. Clin Exp Ophthalmol. 2015;43:40-6. doi:10.1111/CEO.12360
Abdullatif AM, Ahmed El-Saied HM. Various modalities of cyclodestruction in non-refractory glaucoma: a comparative study. Int Ophthalmol. 2021;41:3313-23. doi:10.1007/S10792021-01893-Z/FIGURES/5
Bernardi E, Töteberg-Harms M. Micropulse transscleral laser therapy demonstrates similar efficacy with a superior and more favorable safety profile compared to continuouswave transscleral cyclophotocoagulation. J Ophthalmol. 2022:8566044. doi:10.1155/2022/8566044
Abdelrahman AM, El Sayed YM. Micropulse Versus Continuous Wave Transscleral Cyclophotocoagulation in Refractory Pediatric Glaucoma. J Glaucoma. 2018;27:900-5. doi:10.1097/IJG.0000000000001053
De Crom RM, Slangen CG, Kujovic-Aleksov S, Webers CA, Berendschot TT, Beckers HJ. Micropulse Trans-scleral Cyclo-photocoagulation in Patients With Glaucoma: 1- and 2-Year Treatment Outcomes. J Glaucoma. 2020;29:794-8. doi:10.1097/IJG.0000000000001552
Preda MA, Karancsi OL, Munteanu M, Stanca HT. Clinical outcomes of micropulse transscleral cyclophotocoagulation in refractory glaucoma-18 months follow-up. Lasers Med Sci. 2020;35:1487-91. doi:10.1007/S10103-019-02934-X
Yelenskiy A, Gillette TB, Arosemena A, Stern AG, Garris WJ, Young CT, et al. Patient outcomes following micropulse transscleral cyclophotocoagulation: intermediate-term results. J Glaucoma. 2018;27:920-5. doi:10.1097/IJG.0000000000001023
Marques RE, Ferreira NP, Sousa DC, Barata AD, Sens P, Marques-Neves C, et al. High intensity focused ultrasound for glaucoma: 1-year results from a prospective pragmatic study. Eye. 2021;35:484-9. doi:10.1038/S41433-020-0878-0
Hugo J, Matonti F, Beylerian M, Zanin E, Aptel F, Denis D. Safety and efficacy of high-intensity focused ultrasound in severe or refractory glaucoma. Eur J Ophthalmol. 2021;31:130-7. doi:10.1177/1120672119874594
Leshno A, Rubinstein Y, Singer R, Sher I, Rotenstreich Y, Melamed S, et al. High-intensity focused ultrasound treatment in moderate glaucoma patients: results of a 2-year prospective clinical trial. J Glaucoma. 2020;29:556-60. doi:10.1097/IJG.0000000000001497
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Revista Sociedade Portuguesa de Oftalmologia
This work is licensed under a Creative Commons Attribution 4.0 International License.
CC BY
Do not forget to download the Authorship responsibility statement/Authorization for Publication and Conflict of Interest.
The article can only be submitted with these two documents.
To obtain the Authorship responsibility statement/Authorization for Publication file, click here.
To obtain the Conflict of Interest file (ICMJE template), click here
